230 related articles for article (PubMed ID: 24678958)
21. Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.
Wang S; Xue S; Dai Y; Yang J; Chen Z; Fang X; Zhou W; Wu W; Li Q
Diagn Pathol; 2012 Nov; 7():159. PubMed ID: 23173870
[TBL] [Abstract][Full Text] [Related]
22. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.
Wang Z; Hong Z; Gao F; Feng W
Mol Cell Biochem; 2013 Nov; 383(1-2):59-65. PubMed ID: 23864342
[TBL] [Abstract][Full Text] [Related]
25. High BCL11A Expression in Adult Acute Myeloid Leukemia Patients Predicts a Worse Clinical Outcome.
Dong H; Shi P; Zhou Y; Yu Y; Guo X; Yao Y; Liu P; Xu B
Clin Lab; 2017 Jan; 63(1):85-90. PubMed ID: 28164500
[TBL] [Abstract][Full Text] [Related]
26. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
Dong LL; Chen LM; Wang WM; Zhang LM
Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
[TBL] [Abstract][Full Text] [Related]
29. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
30. Correlation of microRNA-372 upregulation with poor prognosis in human glioma.
Li G; Zhang Z; Tu Y; Jin T; Liang H; Cui G; He S; Gao G
Diagn Pathol; 2013 Jan; 8():1. PubMed ID: 23298385
[TBL] [Abstract][Full Text] [Related]
31. Downregulated Poly-C binding protein-1 is a novel predictor associated with poor prognosis in Acute Myeloid Leukemia.
Zhou M; Tong X
Diagn Pathol; 2015 Aug; 10():147. PubMed ID: 26293996
[TBL] [Abstract][Full Text] [Related]
32. Overexpressed miR-155 is associated with initial presentation and poor outcome in Chinese pediatric acute myeloid leukemia.
Xu LH; Guo Y; Cen JN; Yan WY; He HL; Niu YN; Lin YX; Chen CS; Hu SY
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4841-50. PubMed ID: 26744876
[TBL] [Abstract][Full Text] [Related]
33. High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia.
Zhou LY; Yin JY; Tang Q; Zhai LL; Zhang TJ; Wang YX; Yang DQ; Qian J; Lin J; Deng ZQ
Int J Clin Exp Pathol; 2015; 8(12):16073-80. PubMed ID: 26884884
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
Yang Y; Song KL; Chang H; Chen L
Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
[TBL] [Abstract][Full Text] [Related]
35. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.
Seipel K; Messerli C; Wiedemann G; Bacher U; Pabst T
Leuk Res; 2020 Feb; 89():106296. PubMed ID: 31927137
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
37. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.
Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P
Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
Zhang P; Sun D; Sun X; Li H
Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
[TBL] [Abstract][Full Text] [Related]
39. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
[TBL] [Abstract][Full Text] [Related]
40. Serum miR-22 is a novel prognostic marker for acute myeloid leukemia.
Qu H; Zheng G; Cheng S; Xie W; Liu X; Tao Y; Xie B
J Clin Lab Anal; 2020 Sep; 34(9):e23370. PubMed ID: 32533562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
